Canadian Securities ExchangeThe Daily Bell

Entheon Biomedical

CSE:ENBI

1 video on CSE TV

1 story on the blog

  • Timothy Ko on Treating Addiction with DMT and Psychedelics | The CSE Podcast Ep3-S2CSE’s Barrington Miller catches up with Timothy Ko, CEO of Entheon Biomedical Corp. (CSE:ENBI) to discuss how his company is pursuing R&D of DMT-based products to safely treat addiction. Timothy provides an update on what the company has accomplished in the year since they’ve been public and upcoming plans for clinical trials. Here’s an overview…

    Sep 10, 2021Podcasts(CSE:ENBI)